Abstract
Serological testing and the use of immunochemical techniques are well established in the clinical laboratory and then uses are still rapidly increasing. Serological tests are applied for the diagnosis of infectious diseases, autoimmune disorders, allergies, and malignancies. Yet despite their widespread use, immunoassays are inflicted with a number of significant problems that lead to a substantial variation in reliability and accuracy of currently available tests. In the recent process of establishing procedures and criteria for quality assurance in the clinical laboratory an increased awareness of these problems has arisen among the clinical and reference laboratories as well as among the manufacturers of commercial test kits. The recognition of this situation prompted the US National Committee for Clinical Laboratory Standards (NCCLS) to create specific guidelines that address “the generrc problems of preparation and characterization of antigens and antibodies, testing using these reagents, and understanding the results” These guidelines are made public in the NCCLS document I/LA 18-A Specifications for Immunological Testing for Infectious Diseases; Approved Guideline, issued in December 1994 (1). References to this document will be made in this chapter where appropriate, and particularly, attempts will be made to adhere to the definitions of terms and procedures as they are laid down in the NCCLS consensus document.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
NCCLS (1994) Specifications for immunological testing for infectious diseases; approved guideline, in NCCLS document I/LA 18-A, (ISBN l-56238-251-9). Edited by NCCLS, Villanova, PA 19085.
Brenner H and Gefeller O. (1994) Chance-corrected measures of the validity of a binary diagnostic test. J Clin Epidemiol 47, 627–633
Tosteson ANA, Weinstem M C, Wittenberg J, and Begg C. B (1994) ROC curve regression analysts. the use of ordmal regression models for diagnostic test assessment Environ Health Perspect 102, 73–78
DuJardin B, Vandenende J, Vangompel A, Unger J P., and Vanderstuyft P (1994) Ltkehhood ratios—a real improvement for clinitcal dectston making Eur J Epidemiol 10, 29–36
Vanderschouw Y T, Vandijk R., and Verbeek A L. M (1995) Problems in selecting the adequate patient populatron from existing data files for assessment studies of new diagnostic tests. J Clin Epidemiol 48, 417–422.
Broder C C, Earl P. L, Long D, Abedon S T., Moss B., and Doms R. W (1994) Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure. oligomer-spectfic and-sensitive monoclonal antibodies Proc. Natl Acad Sci USA 91, 11,699–l1,703
Dyson H J and Wright P E (1995) Antigenic peptides FASEB J 9, 37–42.
Gurunath R, Beena T K., Adiga P. R, and Balaram P (1995) Enhancing peptide antigenicity by helix stabilization FEBS Lett 361, 176–178
MukherJee J, Nussbaum G, Scharff M. D., and Casadevall A (1995) Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med 181, 405–409.
Prenttce L, Krso Y, Fukuma N., Horimoto M, Petersen V., Grennan F, Pegg C, Furmamak J, and Smith B. R (1995) Monoclonal thyroglobulin autoantibodies. variable region analysis and epitope recognition J Clin Endocrinol Metab 80, 977–986
Lovrich S. D, Callister S. M, Lim L C L., Duchateau B K., and Schell R. F (1994) Seroprotective groups of Lyme borrehosts spirochetes from North America and Europe. J Infect Dis 170, 115–121
Roost H P, Bachmann M F., Haag A, Kalmke U, Pliska V, Hengartner H, and Zinkernagel R M (1995) Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity Proc NatL Acad Sci USA 92, 1257–1261.
Foote J. and Etsen H. N (1995) Kinetic and affinity limits on antibodies produced during immune responses Proc NatL Acad Sci USA 92, 1254–1256.
Braden B.C and Poljak R. J (1995) Structural features of the reactions between antibodies and protein antigens. FASEB J 9, 9–16.
Yuan R. R., Casadevall A., Sptra G, and Scharff M. D. (1995) Isotype switching from IgG3 to IgG 1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol 154, 1810–1816.
Rademacher T W., Williams P, and Dwek R. A (1994) Agalactosyl glycoforms of IgG autoantrbodies are pathogenic Proc NatL Acad Sci USA 91, 6123–6127
Lund J., Takahasht N., Pound J. D., Goodall M., Nakagawa H, and Jefferts R (1995) Oligosaccharide protein interactions in IgG can modulate recognition by Fc gamma receptors FASEB J 9, 115–119.
Amzel L M and Gaffney B. J. (1995) Structural immunology problems in molecular recognition FASEB J 9, 7–8
Guddat L W, Shan L., Fan Z. C., Andersen K N., Rosauer R., Linthicum D S, and Edmundson A B. (1995) Intramolecular signaling upon complexation FASEB J 9, 101–106.
Soderlund M, Brown C S, Spaan W J M, Hedman L, and Hedman K (1995) Epitope type specific IgG responses to capsid proteins VP1 and VP2 of human parvovnusB 19. J Znfect Dis 172, 1413–1436.
Gray J J., Wreghitt T. G., Mckee T. A., Mcintyre P., Roth C. E, Smith D. J, Sutehall G., Higgins G., Geraghty R., Whetstone R, and Desselberger U. (1995) Internal quality assurance in a clinical virology laboratory. 2 Internal quality control. J. Clin. Patho1 48, 198–202.
Gray J J, Wreghitt T. G, Mckee T. A., Mcintyre P, Roth C E, Smith D. J, Sutehall G., Higgins G., Geraghty R, Whetstone R., and Desselberger U(1995) Internal quality assurance in a chemical virology laboratory 1 Internal quality assessment. J Clin Pathol. 48, 168–173.
Mugan K., Carlson I H, and Westgard J 0 (1994) Planning QC procedures for immunoassays. J Clin Immunoassay 17, 216–222
Dimech W., Bettoh A, Eckert D, Francis B., Hamblin J., Kerr T, Ryan C., and Skurrte I (1992) Multicenter evaluation of five commercial rubella virus mununoglobulin G kits which report in international units per mililiter. J Clin Microbiol 30, 633–641
Place J F, Truchaud A., Ozawa K., Pardue H, and Schnipelsky P. (1994) Use of artificial intelligence in analytical systems for the clinical laboratory Clin Chem Acta 231, S5–S34.
Place J F, Truchaud A, Ozawa K., Pardue H, and Schnipelsky P (1994) Use of artificial intelligence in analytical systems for the clinical laboratory. Ann. Biol. Clin Purrs 52, 729–743.
Winkel P. (1994) Artificlal intelligence within the chemical laboratory.Ann Biol. Clan Puris 52, 277–282
Winkel P (1994) Multivariate analysis and expert systems. Stand J Clin. Lab Invest 54, 12–24.
Sharpe P K and Caleb P (1994) Artificial neural networks within medical dectsion support systems Stand J. Clin. Lab Invest 54, 3–11
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc.
About this protocol
Cite this protocol
Fierz, W. (1998). Basic Problems of Serological Laboratory Diagnosis. In: Reischl, U. (eds) Molecular Diagnosis of Infectious Diseases. Methods in Molecular Medicine™, vol 13. Humana Press, Totowa, NJ. https://doi.org/10.1385/0-89603-485-2:443
Download citation
DOI: https://doi.org/10.1385/0-89603-485-2:443
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-485-3
Online ISBN: 978-1-59259-597-6
eBook Packages: Springer Protocols